Literature DB >> 22499580

Mode of action of pulegone on the urinary bladder of F344 rats.

Mitscheli S Da Rocha1, Puttappa R Dodmane, Lora L Arnold, Karen L Pennington, Muhammad M Anwar, Bret R Adams, Sean V Taylor, Clint Wermes, Timothy B Adams, Samuel M Cohen.   

Abstract

Essential oils from mint plants, including peppermint and pennyroyal oils, are used at low levels as flavoring agents in various foods and beverages. Pulegone is a component of these oils. In a 2-year bioassay, oral administration of pulegone slightly increased the urothelial tumor incidence in female rats. We hypothesized that its mode of action (MOA) involved urothelial cytotoxicity and increased cell proliferation, ultimately leading to tumors. Pulegone was administered by gavage at 0, 75, or 150 mg/kg body weight to female rats for 4 and 6 weeks. Fresh void urine and 18-h urine were collected for crystal and metabolite analyses. Urinary bladders were evaluated by light microscopy and scanning electron microscopy (SEM) and bromodeoxyuridine (BrdU) labeling index. Pulegone and its metabolites, piperitenone, piperitone, menthofuran, and menthone, were tested for cytotoxicity in rat (MYP3) and human (1T1) urothelial cells by the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. No abnormal urinary crystals were observed by light microscopy. Urine samples (18-h) showed the presence of pulegone, piperitone, piperitenone, and menthofuran in both treated groups. By SEM, bladders from treated rats showed superficial necrosis and exfoliation. There was a significant increase in the BrdU labeling index in the high-dose group. In vitro studies indicated that pulegone and its metabolites, especially piperitenone, are excreted and concentrated in the urine at cytotoxic levels when pulegone is administered at high doses to female rats. The present study supports the hypothesis that cytotoxicity followed by regenerative cell proliferation is the MOA for pulegone-induced urothelial tumors in female rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499580     DOI: 10.1093/toxsci/kfs135

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

1.  Screening for human urinary bladder carcinogens: two-year bioassay is unnecessary.

Authors:  Samuel M Cohen
Journal:  Toxicol Res (Camb)       Date:  2018-01-23       Impact factor: 3.524

2.  In vitro biological potential of the essential oil of some aromatic species used in Iranian traditional medicine.

Authors:  Mansureh Ghavam
Journal:  Inflammopharmacology       Date:  2022-03-24       Impact factor: 4.473

3.  Potential Toxicity of the Essential Oil from Minthostachys mollis: A Medicinal Plant Commonly Used in the Traditional Andean Medicine in Peru.

Authors:  Juan Pedro Rojas-Armas; Jorge Luis Arroyo-Acevedo; José Manuel Ortiz-Sánchez; Miriam Palomino-Pacheco; Hugo Jesus Hilario-Vargas; Oscar Herrera-Calderón; Julio Hilario-Vargas
Journal:  J Toxicol       Date:  2019-12-19

4.  Planimetric and Biomechanical Study of Local Effect of Pulegone on Full Thickness Wound Healing in Rat.

Authors:  Zahra Cheraghali; Rahim Mohammadi; Ghader Jalilzadeh-Amin
Journal:  Malays J Med Sci       Date:  2017-10-26

Review 5.  Critical role of toxicologic pathology in a short-term screen for carcinogenicity.

Authors:  Samuel M Cohen; Lora L Arnold
Journal:  J Toxicol Pathol       Date:  2016-05-23       Impact factor: 1.628

6.  Effect of (R)-(+) Pulegone on Ovarian Tissue; Correlation with Expression of Aromatase Cyp19 and Ovarian Selected Genes in Mice.

Authors:  Rohiyeh Souldouzi; Mazdak Razi; Ali Shalizar Jalali; Ghader Jalilzadeh-Amin; Saeedeh Amani
Journal:  Cell J       Date:  2018-03-18       Impact factor: 2.479

7.  Ecological and Plant Community Implication on Essential Oils Composition in Useful Wild Officinal Species: A Pilot Case Study in Apulia (Italy).

Authors:  Enrico V Perrino; Francesca Valerio; Ahmed Gannouchi; Antonio Trani; Giuseppe Mezzapesa
Journal:  Plants (Basel)       Date:  2021-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.